Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542–1556

Article  CAS  PubMed  Google Scholar 

Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010;340:c1240

Article  PubMed  PubMed Central  Google Scholar 

Mallet V, Parlati L, Martinino A, Scarano Pereira JP, Jimenez CN, Sakka M, et al. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. J Hepatol. 2022;76(2):265–274

Article  CAS  PubMed  Google Scholar 

Åberg F, Luukkonen PK, But A, Salomaa V, Britton A, Petersen KM, et al. Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score. J Hepatol. 2022;77(2):302–311

Article  PubMed  Google Scholar 

Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691–702

Article  CAS  PubMed  Google Scholar 

Seo SW, Gottesman RF, Clark JM, Hernaez R, Chang Y, Kim C, et al. Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology. 2016;86(12):1136–1142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK, et al. Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the framingham study. JAMA Neurol. 2018;75(1):97–104

Article  PubMed  PubMed Central  Google Scholar 

Kim GA, Oh CH, Kim JW, Jeong SJ, Oh IH, Lee JS, et al. Association between non-alcoholic fatty liver disease and the risk of dementia: a nationwide cohort study. Liver Int. 2022;42(5):1027–1036

Article  CAS  PubMed  Google Scholar 

Panza F, Frisardi V, Seripa D, Logroscino G, Santamato A, Imbimbo BP, et al. Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry. 2012;27(12):1218–1238

Article  PubMed  Google Scholar 

Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M. Alcohol use and dementia: a systematic scoping review. Alzheimers Res Ther. 2019;11(1):1

Article  PubMed  PubMed Central  Google Scholar 

Aberg F, Byrne CD, Pirola CJ, Mannisto V, Sookoian S. Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol. 2023;78(1):191–206

Article  CAS  PubMed  Google Scholar 

Mikkelsen ACD, Kjærgaard K, Schapira AHV, Mookerjee RP, Thomsen KL. The liver-brain axis in metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2025;10(3):248–258

Article  CAS  PubMed  Google Scholar 

Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the national health insurance service-national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46(2): e15

PubMed  Google Scholar 

Sohn W, Lee YS, Kim SS, Kim JH, Jin YJ, Kim GA, et al. KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025. Clin Mol Hepatol. 2025;31(Suppl):S1-s31

Article  PubMed  PubMed Central  Google Scholar 

Drescher HK, Weiskirchen S, Weiskirchen R. Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Cells. 2019;8(8):845

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeong S, Oh YH, Choi S, Chang J, Kim SM, Son JS, et al. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults. Clin Mol Hepatol. 2022;28(3):510–521

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Wang W, Hou X, Wu J, Wang Y, Fan J, et al. Metabolic-associated steatotic liver disease and risk of Alzheimer’s disease: a real-world retrospective cohort study. Front Endocrinol (Lausanne). 2024;15:1451908

Article  PubMed  PubMed Central  Google Scholar 

Shang Y, Nasr P, Ekstedt M, Widman L, Stal P, Hultcrantz R, et al. Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. JHEP Rep. 2021;3(2): 100218

Article  PubMed  Google Scholar 

Labenz C, Kostev K, Kaps L, Galle PR, Schattenberg JM. Incident dementia in elderly patients with nonalcoholic fatty liver disease in Germany. Dig Dis Sci. 2021;66(9):3179–3185

Article  PubMed  Google Scholar 

Huang H, Liu Z, Xie J, Xu C. NAFLD does not increase the risk of incident dementia: a prospective study and meta-analysis. J Psychiatr Res. 2023;161:435–440

Article  PubMed  Google Scholar 

Palmer ND, Kahali B, Kuppa A, Chen Y, Du X, Feitosa MF, et al. Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer’s disease and myocardial infarction. Hum Mol Genet. 2021;30(15):1443–1456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weinstein G, O’Donnell A, Davis-Plourde K, Zelber-Sagi S, Ghosh S, DeCarli CS, et al. Non-alcoholic fatty liver disease, liver fibrosis, and regional amyloid-beta and tau pathology in middle-aged adults: the framingham study. J Alzheimers Dis. 2022;86(3):1371–1383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang YR, Wang QH, Zhang T, Liu YH, Yao XQ, Zeng F, et al. Associations between hepatic functions and plasma amyloid-beta levels-implications for the capacity of liver in peripheral amyloid-beta clearance. Mol Neurobiol. 2017;54(3):2338–2344

Article  CAS  PubMed  Google Scholar 

Cheon SY, Song J. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell Biosci. 2022;12(1):99

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung I, Park SY, Lee DY, Cho HJ, Lee SK, Seo JA, et al. Association of metabolic dysfunction-associated fatty liver disease with white matter hyperintensity and cognitive decline: a longitudinal cohort study. Diabetes Obes Metab. 2025;27(4):2271–2279

Article  PubMed  Google Scholar 

Hadjihambi A. Cerebrovascular alterations in NAFLD: is it increasing our risk of Alzheimer’s disease? Anal Biochem. 2022;636: 114387

Article  CAS  PubMed  Google Scholar 

Collaborators GBDA. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–1035

Article  Google Scholar 

Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do, “Moderate” drinkers have reduced mortality risk? a systematic review and meta-analysis of alcohol consumption and all-cause mortality. J Stud Alcohol Drugs. 2016;77(2):185–198

Article  PubMed  PubMed Central  Google Scholar 

Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther. 2013;5(1):3

Article  PubMed  PubMed Central  Google Scholar 

Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(1):31–42

Article  PubMed  Google Scholar 

Kim MN, Han JW, An J, Kim BK, Jin YJ, Kim SS, et al. KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease. Clin Mol Hepatol. 2024;30(Suppl):S5-s105

Article  PubMed  PubMed Central